HUP0303349A2 - Szubsztituált bifenilszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerészeti készítmények - Google Patents

Szubsztituált bifenilszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerészeti készítmények

Info

Publication number
HUP0303349A2
HUP0303349A2 HU0303349A HUP0303349A HUP0303349A2 HU P0303349 A2 HUP0303349 A2 HU P0303349A2 HU 0303349 A HU0303349 A HU 0303349A HU P0303349 A HUP0303349 A HU P0303349A HU P0303349 A2 HUP0303349 A2 HU P0303349A2
Authority
HU
Hungary
Prior art keywords
subtituted
preparing
same
pharmaceutical compositions
compositions containing
Prior art date
Application number
HU0303349A
Other languages
English (en)
Inventor
Caroline Bennejean
Hervé Da Costa
Philippe Delagrange
Carole Descamps-Francois
Gérald Guillaumet
Daniel Lesieur
Pierre Renard
Marie-Claude Viaud
Said Yous
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of HUP0303349A2 publication Critical patent/HUP0303349A2/hu
Publication of HUP0303349A3 publication Critical patent/HUP0303349A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/60—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Abstract

A találmány (I) általános képletű vegyületekre vonatkozik, a képletbenB jelentése hidrogénatom- vagy COOR vagy CONRR' általános képletűcsoport vagy COOR, CONRR' vagy OR általános képletű csoporttalszubsztituált 1-6 szénatomos alkilcsoport; G1 jelentése X'-(CH2)n-X-(CH2)m-X< általános képletű csoport, ahol X, X', X<, n és m jelentésea leírás szerinti, Cy jelentése (II) vagy (III) általános képletűcsoport; G2 jelentése a leírás szerinti alkilénlánc és A jelentéseNRCOR', NRCSR', CONRR', CSNRR', NRCONR'R< vagy NRCSNRR< csoport. Atalálmány a vegyületek előállítására szolgáló eljárást és avegyületeket tartalmazó gyógyszerészeti készítményeket is magábanfoglalja. Ó
HU0303349A 2000-09-15 2001-07-16 Subtituted biphenyl derivatives, method for preparing them and pharmaceutical compositions containing the same HUP0303349A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0011779A FR2814165B1 (fr) 2000-09-15 2000-09-15 Nouveaux derives biphenyles substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2001/002297 WO2002022555A1 (fr) 2000-09-15 2001-07-16 Derives biphenyles substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
HUP0303349A2 true HUP0303349A2 (hu) 2004-01-28
HUP0303349A3 HUP0303349A3 (en) 2005-02-28

Family

ID=8854338

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303349A HUP0303349A3 (en) 2000-09-15 2001-07-16 Subtituted biphenyl derivatives, method for preparing them and pharmaceutical compositions containing the same

Country Status (24)

Country Link
US (2) US7161035B2 (hu)
EP (1) EP1317413B1 (hu)
JP (1) JP4015546B2 (hu)
KR (1) KR100580780B1 (hu)
CN (1) CN1233621C (hu)
AT (1) ATE302750T1 (hu)
AU (2) AU2001277595B2 (hu)
BR (1) BR0113907A (hu)
CA (1) CA2419934C (hu)
DE (1) DE60112951T2 (hu)
DK (1) DK1317413T3 (hu)
EA (1) EA005766B1 (hu)
ES (1) ES2248365T3 (hu)
FR (1) FR2814165B1 (hu)
HK (1) HK1058354A1 (hu)
HU (1) HUP0303349A3 (hu)
MX (1) MXPA03002018A (hu)
NO (1) NO20031043D0 (hu)
NZ (1) NZ524330A (hu)
PL (1) PL360574A1 (hu)
PT (1) PT1317413E (hu)
SK (1) SK4692003A3 (hu)
WO (1) WO2002022555A1 (hu)
ZA (1) ZA200301351B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2566158A1 (en) * 2004-05-14 2005-11-24 Abbott Laboratories Kinase inhibitors as therapeutic agents
KR100626438B1 (ko) * 2005-02-24 2006-09-21 웅진코웨이주식회사 산소발생기용 배관 모듈
TR201815422T4 (tr) * 2014-01-14 2018-11-21 Astellas Pharma Inc İndol bileşiği.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093352A (en) * 1988-11-14 1992-03-03 Whitby Research, Inc. Antidepressant agents
DE69616357T2 (de) * 1995-07-26 2002-07-11 Takeda Chemical Industries Ltd Benzocycloalken-verbindungen mit bindungsaffinität an den melatonin-rezeptor, ihre herstellung und verwendung
US5808151A (en) * 1996-04-17 1998-09-15 Bristol-Myers Squibb Company Biphenylamido derivatives as melatonergic agents
FR2771739B1 (fr) * 1997-11-28 2001-04-20 Adir Nouveaux composes naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2772766B1 (fr) * 1997-12-24 2000-06-30 Adir Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2778662B1 (fr) * 1998-05-12 2000-06-16 Adir Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2784375B1 (fr) * 1998-10-12 2000-11-24 Adir Nouveaux derives cycliques a chaine cycloalkylenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
KR100580780B1 (ko) 2006-05-22
US20040014969A1 (en) 2004-01-22
NO20031043L (no) 2003-03-06
NO20031043D0 (no) 2003-03-06
NZ524330A (en) 2004-12-24
CA2419934C (fr) 2008-01-15
CN1233621C (zh) 2005-12-28
DK1317413T3 (da) 2005-11-21
AU7759501A (en) 2002-03-26
ZA200301351B (en) 2004-02-19
US7161035B2 (en) 2007-01-09
AU2001277595B2 (en) 2006-08-17
BR0113907A (pt) 2003-07-22
KR20030059140A (ko) 2003-07-07
CA2419934A1 (fr) 2003-03-21
PT1317413E (pt) 2005-11-30
SK4692003A3 (en) 2003-08-05
JP2004518627A (ja) 2004-06-24
EP1317413B1 (fr) 2005-08-24
WO2002022555A1 (fr) 2002-03-21
ES2248365T3 (es) 2006-03-16
FR2814165B1 (fr) 2002-11-22
HK1058354A1 (en) 2004-05-14
EP1317413A1 (fr) 2003-06-11
JP4015546B2 (ja) 2007-11-28
US20070123529A1 (en) 2007-05-31
FR2814165A1 (fr) 2002-03-22
CN1457337A (zh) 2003-11-19
DE60112951D1 (de) 2005-09-29
PL360574A1 (en) 2004-09-06
MXPA03002018A (es) 2003-07-24
HUP0303349A3 (en) 2005-02-28
DE60112951T2 (de) 2006-06-14
EA200300376A1 (ru) 2003-08-28
EA005766B1 (ru) 2005-06-30
ATE302750T1 (de) 2005-09-15

Similar Documents

Publication Publication Date Title
BG100951A (en) Novel erythromycin derivatives, method for their preparation and their use as drugs
ATE346851T1 (de) Mehrfunktionelle thioxanthon-photoinitiatoren
HUP0302962A2 (hu) Béta-karbolinszármazékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények és a vegyületek alkalmazása
TR200103273T2 (tr) Hemisentetik yöntem ve yeni bileşimler.
HUP0402507A2 (hu) N(fenilszulfonil)glicin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyászati készítmények
ATE517663T1 (de) Photostabile organische sonnenschutzverbindungen mit antioxidationseigenschaften und daraus gewonnene zusammensetzungen
EA200000431A2 (ru) Новые замещенные димерные соединения, способ их получения и фармацевтические композиции, содержащие их
HUP0003484A2 (hu) Pirrolidin-3-karbonsav-származékok és alkalmazásuk endotelin antagonistaként
EA200300044A1 (ru) Новые замещенные фталиды, способ их получения и содержащие их фармацевтические композиции
CY1105939T1 (el) Παραγωγα βενζοθειαζινης και βενζοθεαδιαζινης, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις οι οποιες τα πepιεχουν
DK0763024T3 (da) Fremgangmåde og mellemprodukter til fremstilling af piperazinderivater
HK1050532A1 (en) Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
MD522F1 (en) New piperidine thyoindol derivatives, method for preparation, pharmaceutical compositions containing them, using of them as analgetics.
HUP0303349A2 (hu) Szubsztituált bifenilszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerészeti készítmények
DE3769563D1 (de) Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung.
EP0335979A4 (en) Thienopyrimidine derivatives
UA41871C2 (uk) Похідні еритроміцину, спосіб їх одержання та фармацевтична композиція на їх основі
GR3029590T3 (en) Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
NO20001541L (no) Nye substituerte dimeriske forbindelser, fremgangsmÕte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem
RU93033697A (ru) Производные 2-амино-n-[[[4-(аминокарбонил) пиримидин-2-ил]амино] алкил] пиримидин-4-карбоксамида, способ их получения и фармацевтическая композиция на их основе
IL154165A0 (en) Method for the production of imidazo-(1,2-c) (2,3)-benzodiazepines and intermediates in the production thereof
ATE370143T1 (de) Vollständige synthese der galanthamin, deren analogen und derivaten
EA200000373A2 (ru) Новые соединения 1-аза-2-алкил-6-арилциклоалкана, способ их получения и содержащие их фармацевтические композиции
ES2187334A1 (es) Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
HUP0400531A2 (hu) Gyulladásgátló szerekként alkalmazható hidantoinvegyületek és ezeket tartalmazó gyógyszerkészítmények

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished